No 10Y consistency score for revenue — its stored periods are half-year spaced, so quarter-over-same-quarter consistency is not computed.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annual revenue · last 9 fiscal years
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
The latest delayed quote for Paranovus Entertainment Technology Ltd. (PAVS) stock was $3.79 as of Oct 6, 2026, 12:19 PM EDT, up 0.53% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -100.0% · 3-year avg -97.8%/yr · 5-year avg -93.0%/yr
Paranovus Entertainment Technology Ltd. operates in the artificial intelligence (AI)-powered entertainment industry.
Medical - Pharmaceuticals · New York, NY
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Jan 15, 2027
101 days away
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$-75.22
vs Estimate
N/A
Revenue
$2.19M
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1PAVS | $3.25M | $3.79 | +0.53% | -100.00% | -92.96% | N/A | N/A |
| 2AEMD | $3.28M | $6.23 | -4.52% | -83.19% | -78.27% | -65.74% | vs PAVS |
| 3ICCM | $3.18M | $1.41 | -8.40% | -94.60% | -63.05% | N/A | vs PAVS |
| 4MBAI | $3.17M | $3.16 | +3.27% | N/A | N/A | N/A | vs PAVS |
| 5REVB | $3.12M | $0.80 | +2.56% | -86.98% | -93.52% | N/A | vs PAVS |
| 6BRTX | $3.07M | $2.23 | -0.67% | -92.40% | -61.44% | -68.97% | vs PAVS |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$3.79
High
N/A
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $2112000.00 | $2112000.00 | $2112000.00 | 1 |
| FY 2028 | $2112000.00 | $2112000.00 | $2112000.00 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $72.22M | $72.22M | $72.22M | 1 |
| FY 2028 | $72.22M | $72.22M | $72.22M | 1 |
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
